Sanjivani Paranteral Limited

BSE:531569 Stock Report

Market Cap: ₹4.4b

Sanjivani Paranteral Past Earnings Performance

Past criteria checks 3/6

Sanjivani Paranteral has been growing earnings at an average annual rate of 47.9%, while the Pharmaceuticals industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 24.4% per year. Sanjivani Paranteral's return on equity is 21.7%, and it has net margins of 11.1%.

Key information

47.9%

Earnings growth rate

48.3%

EPS growth rate

Pharmaceuticals Industry Growth17.5%
Revenue growth rate24.4%
Return on equity21.7%
Net Margin11.1%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Sanjivani Paranteral makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BSE:531569 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2462469530
30 Jun 2458363430
31 Mar 2454462430
31 Dec 2349759490
30 Sep 2343852410
30 Jun 2338243350
31 Mar 2335545330
31 Dec 2232649350
30 Sep 2231157360
30 Jun 2232460310
31 Mar 2230648350
31 Dec 2132648320
30 Sep 2129834300
30 Jun 2128325260
31 Mar 2125114280
31 Dec 20217-2270
30 Sep 20199-11280
30 Jun 20175-17270
31 Mar 20164-17280
31 Dec 19179-12300
30 Sep 19234-13300
30 Jun 19233-23280
31 Mar 19251-21300
31 Dec 18238-216280
30 Sep 18195-229290
30 Jun 18187-462290
31 Mar 18182-531370
31 Dec 17209-438350
30 Sep 17266-458370
30 Jun 17281-233280
31 Mar 17328-262330
31 Dec 16322-233320
30 Sep 16562-190300
30 Jun 16812-159270
31 Mar 161,156-146310
31 Dec 151,474-22570
30 Sep 151,460-24580
30 Jun 151,394-31330
31 Mar 151,330-24300
31 Dec 141,3695730
30 Sep 141,47017740
30 Jun 141,59620750
31 Mar 141,58916770
31 Dec 131,54434940

Quality Earnings: 531569 has a high level of non-cash earnings.

Growing Profit Margin: 531569's current net profit margins (11.1%) are lower than last year (11.9%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 531569 has become profitable over the past 5 years, growing earnings by 47.9% per year.

Accelerating Growth: 531569's earnings growth over the past year (32.9%) is below its 5-year average (47.9% per year).

Earnings vs Industry: 531569 earnings growth over the past year (32.9%) exceeded the Pharmaceuticals industry 20.4%.

Return on Equity

High ROE: 531569's Return on Equity (21.7%) is considered high.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 02:12
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sanjivani Paranteral Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution